Shin Kan

1.2k total citations
32 papers, 808 citations indexed

About

Shin Kan is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Shin Kan has authored 32 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 18 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Shin Kan's work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immune Cell Function and Interaction (9 papers). Shin Kan is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immune Cell Function and Interaction (9 papers). Shin Kan collaborates with scholars based in Japan, United States and France. Shin Kan's co-authors include Masato Okamoto, Shigeo Koido, Sadamu Homma, Masaki Ito, Yoshitaka Sunami, Akimichi Ohsaka, Soji Morishita, Yumi Hironaka, Marito Araki and Norio Komatsu and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Shin Kan

32 papers receiving 801 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Shin Kan	392	368	276	203	161	32	808
Floris Dammeijer	389 1.0×	429 1.2×	284 1.0×	329 1.6×	130 0.8×	15	953
Jeffrey J. Pu	241 0.6×	269 0.7×	214 0.8×	115 0.6×	143 0.9×	50	686
Ana Pilar González	524 1.3×	491 1.3×	164 0.6×	258 1.3×	109 0.7×	45	1.0k
Fanqi Bai	305 0.8×	637 1.7×	290 1.1×	240 1.2×	307 1.9×	24	1.0k
Myriam Foglietta	357 0.9×	573 1.6×	162 0.6×	102 0.5×	194 1.2×	29	805
Leticía Huergo-Zapico	349 0.9×	540 1.5×	145 0.5×	156 0.8×	85 0.5×	19	775
Andreas Draube	413 1.1×	501 1.4×	215 0.8×	94 0.5×	187 1.2×	30	807
Sijie Lu	688 1.8×	904 2.5×	254 0.9×	78 0.4×	172 1.1×	25	1.3k
Takehide Akiyama	272 0.7×	167 0.5×	263 1.0×	164 0.8×	446 2.8×	28	825
I G Schmidt-Wolf	653 1.7×	636 1.7×	190 0.7×	60 0.3×	96 0.6×	24	1.0k

Countries citing papers authored by Shin Kan

Since Specialization

Citations

This map shows the geographic impact of Shin Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin Kan more than expected).

Fields of papers citing papers by Shin Kan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin Kan. The network helps show where Shin Kan may publish in the future.

Co-authorship network of co-authors of Shin Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Shin Kan. A scholar is included among the top collaborators of Shin Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin Kan. Shin Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koido, Shigeo, Junichi Taguchi, Shin Kan, et al.. (2024). Dendritic cells pulsed with multifunctional Wilms’ tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 12(10). e009765–e009765. 13 indexed citations

Koido, Shigeo, Sankichi Horiuchi, Shin Kan, et al.. (2022). The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions. Scientific Reports. 12(1). 10698–10698. 4 indexed citations

Ito, Zensho, Machi Suka, Shin Kan, et al.. (2021). Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma. BMC Cancer. 21(1). 1197–1197. 27 indexed citations

Ito, Zensho, Shin Kan, Sankichi Horiuchi, et al.. (2019). Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1. Oncology. 97(3). 135–148. 10 indexed citations

Sunami, Yoshitaka, Marito Araki, Shin Kan, et al.. (2017). Histone Acetyltransferase p300/CREB-binding Protein-associated Factor (PCAF) Is Required for All-trans-retinoic Acid-induced Granulocytic Differentiation in Leukemia Cells. Journal of Biological Chemistry. 292(7). 2815–2829. 20 indexed citations

Araki, Marito, Yinjie Yang, Nami Masubuchi, et al.. (2016). Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms. Blood. 127(10). 1307–1316. 194 indexed citations

Kan, Shin, Shigeo Koido, Masato Okamoto, et al.. (2015). Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine. Oncology Reports. 34(1). 504–510. 25 indexed citations

Kan, Shin, Shigeo Koido, Masato Okamoto, et al.. (2015). Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells. BMC Cancer. 15(1). 726–726. 24 indexed citations

Koido, Shigeo, Sadamu Homma, Shin Kan, et al.. (2014). Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. International Journal of Oncology. 45(1). 470–478. 8 indexed citations

10.

Koido, Shigeo, Masaki Ito, Yukiko Sagawa, et al.. (2014). Vaccination with vascular progenitor cells derived from induced pluripotent stem cells elicits antitumor immunity targeting vascular and tumor cells. Cancer Immunology Immunotherapy. 63(5). 459–468. 6 indexed citations

11.

Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Fusions between dendritic cells and whole tumor cells as anticancer vaccines. OncoImmunology. 2(5). e24437–e24437. 40 indexed citations

12.

Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2013). Prognostic Impact of Expression of Bcl-2 and Bax Genes in Circulating Immune Cells Derived from Patients with Head and Neck Carcinoma. Neoplasia. 15(3). 305–IN35. 18 indexed citations

13.

Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions. OncoImmunology. 2(9). e25994–e25994. 11 indexed citations

14.

Tano, Tomoyuki, Masato Okamoto, Shin Kan, et al.. (2013). Immunochemoradiotherapy for Patients with Oral Squamous Cell Carcinoma: Augmentation of OK-432-Induced Helper T Cell 1 Response by 5-FU and X-ray Irradiation. Neoplasia. 15(7). 805–814. 17 indexed citations

15.

Koido, Shigeo, Sadamu Homma, Masato Okamoto, et al.. (2013). Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation. OncoImmunology. 2(8). e25375–e25375. 7 indexed citations

16.

Oshikawa, Tetsuya, Masato Okamoto, Tomoyuki Tano, et al.. (2006). Antitumor Effect of OK-432–Derived DNA. Journal of Immunotherapy. 29(2). 143–150. 21 indexed citations

17.

Oshikawa, Tetsuya, Masato Okamoto, Sharif Ahmed, et al.. (2005). TX‐1877, a bifunctional hypoxic cell radiosensitizer, enhances anticancer host response: Immune cell migration and nitric oxide production. International Journal of Cancer. 116(4). 571–578. 8 indexed citations

18.

Okamoto, Masato, Tetsuya Oshikawa, Tomoyuki Tano, et al.. (2005). Mechanism of Anticancer Host Response Induced by OK-432, a Streptococcal Preparation, Mediated by Phagocytosis and Toll-Like Receptor 4 Signaling. Journal of Immunotherapy. 29(1). 78–86. 55 indexed citations

19.

Oshikawa, Tetsuya, Masato Okamoto, Tomoyuki Tano, et al.. (2005). Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent. International Immunopharmacology. 6(5). 764–773. 5 indexed citations

20.

Ahmed, Sharif, Masato Okamoto, Tetsuya Oshikawa, et al.. (2004). Anti-Tumor Effect of an Intratumoral Administration of Dendritic Cells in Combination with TS-1, an Oral Fluoropyrimidine Anti-Cancer Drug, and OK-432, a Streptococcal Immunopotentiator. Journal of Immunotherapy. 27(6). 432–441. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact